Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization - Abuodeh, Yazan; Naghavi, Arash O; Ahmed, Kamran A; Venkat, Puja S; Kim, Youngchul; Kis, Bela; Choi, Junsung; Biebel, Benjamin; Sweeney, Jennifer; Anaya, Daniel A; Kim, Richard; Malafa, Mokenge; et al. (World journal of gastroenterology : WJG, 2016)
Keywords: Aged; Aged, 80 and over; Carcinoma, Hepatocellular - diagnostic imaging; Carcinoma, Hepatocellular - mortality; Carcinoma, Hepatocellular - radiotherapy; Carcinoma, Hepatocellular - secondary; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Embolization, Therapeutic - adverse effects; Embolization, Therapeutic - methods; Female; Florida; Fluorodeoxyglucose F18 - administration & dosage; Humans; Kaplan-Meier Estimate; Liver Neoplasms - diagnostic imaging; Liver Neoplasms - mortality; Liver Neoplasms - pathology; Liver Neoplasms - radiotherapy; Male; Microspheres; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals - administration & dosage; Radiopharmaceuticals - adverse effects; Retrospective Studies; Retrospective Study; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes - administration & dosage; Yttrium Radioisotopes - adverse effects; Hepatocellular carcinoma; Biomarker; F-18 fluorodeoxyglucose PET; Prognosis; Radioembolization